24 results
DEFA14A
CBAY
Cymabay Therapeutics Inc
5 Jun 20
Additional proxy soliciting materials
5:07pm
company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that, due to public health and safety
8-K
EX-99.1
CBAY
Cymabay Therapeutics Inc
11 May 20
CymaBay Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:02pm
of CymaBay’s actions will be guided by a commitment to taking all steps possible to ensure the health and safety of its employees.
Held $176.2 million
DEFA14A
CBAY
Cymabay Therapeutics Inc
11 May 20
Additional proxy soliciting materials
4:05pm
of CymaBay’s actions will be guided by a commitment to taking all steps possible to ensure the health and safety of its employees.
Held $176.2 million
10-12G/A
EX-10.22
CBAY
Cymabay Therapeutics Inc
19 Sep 13
Registration of securities (amended)
12:00am
, including health and safety rules, security regulations, sexual harassment, and other instructions issued by Metabolex, which will be made available
8-K
EX-1.1
32ciwhsyeb0fjqzp
18 Nov 21
Other Events
5:18pm
8-K
EX-1.1
dvy5yed1 6la255j
12 Sep 23
Other Events
4:05pm
SC TO-T
EX-99
6sbwt8wke9k3chayjls
23 Feb 24
Third party tender offer statement
6:09am
8-K
EX-1.1
xg8ws2 4b9xc1ii
15 Jul 15
Other Events
12:00am
SC TO-C
EX-2.1
mfuz 3glzz4i4my
12 Feb 24
Information about tender offer
8:39am
8-K
EX-2.1
axbegxzzqa
12 Feb 24
Entry into a Material Definitive Agreement
8:42am
8-K
EX-1.1
rwhvxtrn7zx4
6 Mar 19
Other Events
4:33pm
PRER14A
d28wc
5 May 20
Preliminary revised proxy
4:25pm
PREC14A
9uhzks2k
27 Apr 20
Preliminary proxy with contested solicitation
4:42pm